Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
FUTURE ONCOLOGY, vol.13, no.22, pp.1911-1913, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Editorial Material
- Volume: 13 Issue: 22
- Publication Date: 2017
- Doi Number: 10.2217/fon-2017-0270
- Journal Name: FUTURE ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1911-1913
- Ankara Yıldırım Beyazıt University Affiliated: Yes